• Welcome to our NEW website!

Cart 0

Fifty new monoclonals for cancer research released

 

We are delighted to release 50 new PrecisA Monoclonals focusing on protein targets for cancer research, including markers for cancer processes and different tumor types.


Left: IHC staining of human renal cancer using the new Anti-PAX8 antibody (AMAb91488) shows moderate to strong nuclear positivity in tumor cells . Middle IHC staining of human breast cancer using the new Anti-KRT7 antibody (AMAb91531) shows strong cytoplasmic positivity in tumor cells. Right: IHC staining of human prostate cancer using the new Androgen Receptor Anti-AR antibody (AMAb91547) shows strong nuclear positivity in tumor cells.

Among the new additions are mouse monoclonal antibodies targeting PAX2, PAX8, BCL2, KRT7, MUC1, AR, GATA3, and MUC2.